StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-07 | $7.56 | $7.56 | +0.00% | 0.0M |
| 05-08 | $7.48 | $7.48 | +0.00% | 0.0M |
| 05-14 | $7.36 | $7.40 | +0.61% | 0.0M |
| 05-18 | $7.31 | $7.64 | +4.58% | 0.0M |
| 05-21 | $7.96 | $7.64 | -3.96% | 0.0M |
No sell-side coverage available for GYRO yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Next report date, year-over-year trend, and recent quarter history.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2015 2015-08-31 | Annual 2014 2014-12-31 | Q3 2014 2014-09-30 |
|---|---|---|---|
Revenue | $1.83M | $2.80M | $2.00M |
Operating Income | $-2.82M | $-4.28M | $-2.79M |
Net Income | $-2.50M | $-3.11M | $-2.23M |
EPS (Diluted) | Not available | Not available | Not available |
Total Assets | Not available | $43.88M | Not available |
Total Liabilities | Not available | $20.42M | Not available |
Cash & Equivalents | $7.47M | $4.03M | $4.38M |
Free Cash Flow OCF − CapEx | $-2.71M | $-6.40M | $-5.88M |
Shares Outstanding | Not available | 1.48M | Not available |
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Each factor shows GYRO's percentile within the scored universe — observational ranking, not a recommendation.
Gyrodyne LLC is a United States-based limited liability company. It is engaged in the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) counties, New York.